Company
Seres Therapeutics, Inc. (MCRB)
Standardized SEC financial data for Seres Therapeutics, Inc. — income statement, balance sheet, cash flow and 40+ ratios, as a clean JSON API. CIK 0001609809 · NASDAQ · Pharmaceutical Preparations.
Return on equity
12.9%
ROIC
-74.4%
Free cash flow
$865K
Debt / equity
2.49×
Current ratio
2.56×
EPS (diluted)
$0.64
Ratios for fiscal year 2025, standardized from SEC filings.
Income statement
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Revenue | $33.2M | $144.9M | $7.1M | $0 | $0 | $789K |
| R&D expense |
Balance sheet
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Cash & equivalents | $116.0M | $188.0M | $171.2M | $136.2M | $39.5M | $54.4M |
| Inventory |
Cash flow
| USD | FY2020 | FY2021 | FY2022 | FY2023 | FY2024 | FY2025 |
|---|---|---|---|---|---|---|
| Operating cash flow | -$93.6M | $6.7M | -$228.8M | -$117.4M | -$148.6M | $1.1M |
| Capital expenditures |
Get MCRB data via API
# JSON
curl https://sec-financial-api-production.up.railway.app/v1/company/MCRB/financials \
-H "X-API-Key: YOUR_KEY"
# CSV export (income / balance / cash-flow)
curl "https://sec-financial-api-production.up.railway.app/v1/company/MCRB/income-statement?format=csv" \
-H "X-API-Key: YOUR_KEY"